These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21328546)

  • 41. A mutational analysis of the ColE1-encoded cell cycle regulator Rcd confirms its role in plasmid stability.
    Balding C; Blaby I; Summers D
    Plasmid; 2006 Jul; 56(1):68-73. PubMed ID: 16442621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formation and oral administration of alginate microspheres loaded with pDNA coding for lymphocystis disease virus (LCDV) to Japanese flounder.
    Tian JY; Sun XQ; Chen XG
    Fish Shellfish Immunol; 2008 May; 24(5):592-9. PubMed ID: 18328731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography.
    Wils P; Escriou V; Warnery A; Lacroix F; Lagneaux D; Ollivier M; Crouzet J; Mayaux JF; Scherman D
    Gene Ther; 1997 Apr; 4(4):323-30. PubMed ID: 9176518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneous oxygen availability affects the titer and topology but not the fidelity of plasmid DNA produced by Escherichia coli.
    Jaén KE; Sigala JC; Olivares-Hernández R; Niehaus K; Lara AR
    BMC Biotechnol; 2017 Jul; 17(1):60. PubMed ID: 28676110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vector Design for Improved DNA Vaccine Efficacy, Safety and Production.
    Williams JA
    Vaccines (Basel); 2013 Jun; 1(3):225-49. PubMed ID: 26344110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation detection in plasmid-based biopharmaceuticals.
    Oliveira PH; Prather KL; Prazeres DM; Monteiro GA
    Biotechnol J; 2011 Apr; 6(4):378-91. PubMed ID: 21328546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural instability of plasmid biopharmaceuticals: challenges and implications.
    Oliveira PH; Prather KJ; Prazeres DM; Monteiro GA
    Trends Biotechnol; 2009 Sep; 27(9):503-11. PubMed ID: 19656584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM; Prather KL
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomedical application of plasmid DNA in gene therapy: a new challenge for chromatography.
    Sousa F; Passarinha L; Queiroz JA
    Biotechnol Genet Eng Rev; 2010; 26():83-116. PubMed ID: 21415877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasmid DNA for pharmaceutical applications.
    Schleef M; Schmidt T; Flaschel E
    Dev Biol (Basel); 2000; 104():25-31. PubMed ID: 11713820
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.